Table IV.
GSE76211 | GSE40355 | |||||
---|---|---|---|---|---|---|
miRNAs | Fold-change | P-value | Featurea | Fold-change | P-value | Featurea |
hsa-miR-497-5p | −3.27 | 0.011865 | Down | −7.94 | 5.94×10−5 | Down |
hsa-miR-29a-3p | −2.90 | 0.02804 | Down | −3.61 | 0.0003 | Down |
hsa-miR-124-3p | −1.70 | 0.025797 | Down | – | – | Down |
hsa-miR-4269 | −8.22 | 0.038312 | Down | – | – | Down |
hsa-miR-145-5p | −3.49 | 0.005372 | Down | −52.69 | 4.39×10−8 | Down |
hsa-miR-204-5p | −6.00 | 0.015525 | Down | −463.33 | 1.89×10−10 | Down |
hsa-miR-4510 | −2.80 | 0.004545 | Down | – | – | Down |
hsa-miR-6840-3p | −6.81 | 0.024616 | Down | – | – | Down |
hsa-miR-6722-3p | −2.90 | 0.011275 | Down | – | – | Down |
Changes of miRNA expression in MIBC compared with normal bladder. miRNA/miR, microRNA; MIBC, muscle invasive bladder cancer; Down, downregulated in MIBC.